Results
1
Stocks which the market has priced substantially different to their cash flows, which could imply risk.
1 companies
Kamada
Market Cap: ₪1.4b
Manufactures and sells plasma-derived protein therapeutics.
KMDA
₪24.10
7D
11.1%
1Y
1.0%